Remdesivir has “little or no effect on mortality” for patients hospitalized with coronavirus and it doesn’t seem to help Covid-19 patients recover any faster, either.

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

There are also some drugs that have been approved for one purpose, and they may have some efficacy against COVID-19. So there's actually a heartburn drug that's being tried.

Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases. Coronavirus drugs: Where we are and what we know ...

A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and ... Research highlights media misrepresentation of COVID-19 drug efficacy.

The study looked at a variety of literature for drug therapies for COVID-19 -- including hydroxychloroquine, remedesivier, tocilizumab and steroids -- on PubMed.

A new class of drugs could prevent resistant COVID-19 variants, study finds. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2023 / 03 / 230308171657.htm ...

Moderna’s Covid-19 vaccine showed 93% efficacy against symptomatic disease through six months, and the company expects to complete its application for full approval from the US Food and Drug ...

The SARS-CoV-2 macro domain protein bound to small molecule fragments that could be the basis of novel antiviral drugs. Editor’s note: A manuscript detailing the findings was posted to the bioRxiv ...

The drug might even be more efficient at blocking the novel coronavirus, SARS-CoV-2, than remdesivir, a drug being tested against COVID-19 in clinical trials that began in March.

Preliminary results from a late-stage study examining the efficacy of the Oxford-AstraZeneca vaccine indicate it is significantly effective at preventing severe illness from COVID-19. Results of ...